MOLN — Molecular Partners AG Cashflow Statement
0.000.00%
Last trade - 00:00
- $162.10m
- -$20.02m
- CH₣7.04m
- 35
- 20
- 54
- 29
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -36.3 | -62.8 | -63.8 | 118 | -62 |
Depreciation | |||||
Non-Cash Items | 2.54 | 8.64 | 5.53 | 5 | 6.62 |
Other Non-Cash Items | |||||
Changes in Working Capital | 30.1 | 22.3 | -35.3 | -6.67 | -6.06 |
Change in Accounts Receivable | |||||
Change in Prepaid Expenses | |||||
Change in Accrued Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -1.19 | -29 | -91 | 119 | -59 |
Capital Expenditures | -1.86 | -1.68 | -1.31 | -1.42 | -0.808 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -18 | -20.1 | -20.9 | -99.7 | 45.4 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -19.8 | -21.7 | -22.2 | -101 | 44.6 |
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -0.227 | 113 | 50.6 | -1.57 | -1.17 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -23.2 | 58 | -61.9 | 16.1 | -20.6 |